- Home
- SVM vs VIR Comparison
SVM vs VIR Comparison
Compare SVM & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVM | VIR |
|---|---|---|
| Founded | N/A | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.5B |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SVM | VIR |
|---|---|---|
| Price | $11.96 | $9.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $10.50 | ★ $19.43 |
| AVG Volume (30 Days) | ★ 2.5M | 1.5M |
| Earning Date | 05-25-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.22% | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $68,556,000.00 |
| Revenue This Year | $36.87 | $270.22 |
| Revenue Next Year | $35.34 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.29 | $4.25 |
| 52 Week High | $15.77 | $11.66 |
Technical Indicators
Market Signals| Indicator | SVM | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 63.01 | 51.93 |
| Support Level | $11.45 | $8.43 |
| Resistance Level | $13.29 | $9.80 |
| Average True Range (ATR) | 0.56 | 0.40 |
| MACD | 0.28 | 0.04 |
| Stochastic Oscillator | 75.86 | 58.10 |
Price Performance
Historical ComparisonAbout SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is engaged in the acquisition, exploration, development, and mining of mineral properties. The Company's producing mines are located in China, and current exploration and development projects are located in China, Ecuador and Kyrgyz Republic. The company operates in single segment. The Company mainly produces and sells silver, lead, zinc, gold and other metals. The company's producing projects are Ying Mining District, GC Mine; construction projects are El Domo; permitting project is BYP Mine; development project includes Condor, Tulkubash/Kyzyltash.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.